Advanced Wound Care Market to Depict 6.1% CAGR from 2024 to 2032; Carolina Caring Launched Wound Care Program to Promote Faster Healing

The global advanced wound care market size stood at USD 11.98 billion in 2023. The market value is slated to rise from USD 12.62 billion in 2024 to USD 20.33 billion by 2032 at a CAGR of 6.1% during 2024-2032. The expansion is propelled by the surging prevalence of chronic diseases and the increasing adoption of various products such as skin grafts, NPWT, and substitutes for wound treatment.

Fortune Business Insights™ presents this information in its report titled “Advanced Wound Care Market Size, Share & COVID-19 Impact Analysis, By Product Type (Advanced Wound Dressings {Alginate Dressings, Hydrogel Dressings, Film Dressings, Hydrocolloid Dressings, Antimicrobial Dressings, Foam Dressings, and Others}, Wound Care Devices {Negative Pressure Wound Therapy (NPWT), Hyperbaric Oxygen Therapy (HBOT), Extracorporeal Shock Wave Therapy (ESWT), and Others}, and Active Wound Care {Biological Skin Equivalents, Growth Factors, Biological Dressings, and Others}), By Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds, and Others), By End User (Hospitals, Clinics, Homecare Settings, and Others), and Regional Forecast, 2024-2032”.

Product Demand Declined due to Cancellation of Non-Emergency Procedures Amid Coronavirus Pandemic

The pandemic led to the cancellation of non-emergency procedures, affecting the market growth to a certain extent. The reallocation of healthcare resources such as medical devices, nurses, and hospital beds led to the exemption of wound care from the list of emergency procedures. Furthermore, healthcare facilities were closed, considerably impacting the number of patient visits for availing wound care services.

Amferia Raised USD 1.8 Million to Roll out New Products

In January 2023, Amferia raised USD 1.8 million for accelerating the rollout of a new antimicrobial wound care dressing product. The funding was raised from Chalmers Ventures, Almi Invest, and a series of angel investors.

The financing was aimed at supporting the launch of Amferia’s first wound care dressing solution. The product was claimed to contain a patented hydrogel focused on killing antibiotic-resistant bacteria and combating infections.

Dressings Demand to Escalate with Growing Incidences of Acute and Chronic Wounds

The advanced wound care market growth is being propelled by the surging incidences of chronic wounds and the increasing disease burden among people of old age. The market expansion is further impelled by the escalating launch of products with better healing properties.

However, the market expansion could be affected by the lack of reimbursement policies in emerging countries.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/advanced-wound-care-market-100060

Leading Companies Launch New Solutions to Secure a Competitive Edge

Major industry participants are centered on the development and rollout of various initiatives for strengthening the positions of their businesses. These advanced wound care companies are undertaking research activities for the same. Additional steps include merger agreements, acquisitions, and partnership deals.

Key Players Profiled:

• Smith & Nephew (U.K.)


• 3M (U.S.)


• MiMedx (Georgia)


• Coloplast Corp (Denmark)


• ConvaTec Inc. (U.K.)


• Tissue Regenix (U.S.)


• Derma Sciences Inc. (U.S.)


• Mölnlycke Health Care AB (Sweden)


• Organogenesis Inc. (U.S.)


• Integra LifeSciences (U.S.)

Notable Industry Development

• October 2021 – Carolina Caring rolled out a wound care program in partnership with Paul Hartmann, U.S. The deal was launched for aiding patients in faster wound healing and the management of chronic wounds.

Further Report Findings

• The North America advanced wound care market share is anticipated to depict exceptional growth, dominating the global market over the estimated period. The rise is on account of the soaring prevalence of chronic and acute wounds in the region.


• The Europe market is expected to grow at a considerable CAGR over the forecast period. The surge is propelled by the increasing awareness associated with the availability of treatment for chronic wounds.


• By product type, the market for advanced wound care is classified into active wound care, advanced wound dressings, and wound care devices. The advanced wound dressings segment share is set to rise driven by the advantages of lower cost and high efficiency.


• Based on indication, the market is segmented into surgical wounds, diabetic foot ulcers, pressure ulcers, and others. The diabetic foot ulcers segment is expected to register appreciable expansion throughout the projected period.

Table of Segmentation